News

HTM Completes NIH Commercialization Accelerator Program

Alan M. Letzt, President and CEO of Healthcare Technologies and Methods, LLC (HTM), is pleased to report that, “HTM has successfully completed NIH’s Commercialization Accelerator Program (CAP) and is excited about applying the TELLYHealth commercialization strategies developed during the program.”

The NIH CAP is a 9-month program that is designed to advance the commercialization objectives of companies that have received Phase II NIH SBIR grants. The program provides individualized assistance that enables participants to establish market and customer relevance, build commercial relationships, and focus on targeted revenue opportunities. Applicants are selected to participate in this NIH-funded program via a highly competitive process. Over the past 14 years, more than 1,000 companies have participated in the NIH CAP with many resulting success stories.

About Us

HTM is a unique interdisciplinary healthcare company that specializes in processes and technologies for improved patient education and patient—provider communications. Our hallmarks include excellence in system usability, health literacy, and individualized patient-centered care.

Latest News

Social Media

Keep up with our latest news and information by following us on Linked In or reading our news feed.